NDC 0480-4514

Pemetrexed

Pemetrexed

Pemetrexed is a Intravenous Solution, Concentrate in the Human Prescription Drug category. It is labeled and distributed by Teva Pharmaceuticals, Inc.. The primary component is Pemetrexed Monohydrate.

Product ID0480-4514_358c3982-007b-43db-8cb6-9777f9488510
NDC0480-4514
Product TypeHuman Prescription Drug
Proprietary NamePemetrexed
Generic NamePemetrexed
Dosage FormSolution, Concentrate
Route of AdministrationINTRAVENOUS
Marketing Start Date2022-05-31
Marketing CategoryNDA /
Application NumberNDA208419
Labeler NameTeva Pharmaceuticals, Inc.
Substance NamePEMETREXED MONOHYDRATE
Active Ingredient Strength25 mg/mL
Pharm ClassesFolate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0480-4514-01

1 VIAL, SINGLE-DOSE in 1 CARTON (0480-4514-01) > 20 mL in 1 VIAL, SINGLE-DOSE
Marketing Start Date2022-05-31
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Pemetrexed" or generic name "Pemetrexed"

NDCBrand NameGeneric Name
0338-0720PEMETREXEDPEMETREXED
0338-0722PEMETREXEDPEMETREXED
0409-1045PEMETREXEDPEMETREXED
0409-1060PemetrexedPemetrexed
0409-1061PemetrexedPemetrexed
0409-1062PemetrexedPemetrexed
0409-2188PEMETREXEDPEMETREXED
0409-3532PEMETREXEDPEMETREXED
0480-4514PemetrexedPemetrexed
0480-4515PemetrexedPemetrexed
0480-4516PemetrexedPemetrexed
0781-3518PemetrexedPemetrexed disodium
0781-3519PemetrexedPemetrexed disodium
0781-3520PemetrexedPemetrexed disodium
16729-229PemetrexedPemetrexed
16729-230PemetrexedPemetrexed
16729-244PemetrexedPemetrexed
16729-522PemetrexedPemetrexed disodium
50742-340PemetrexedPemetrexed disodium
50742-341PemetrexedPemetrexed disodium
55150-381PemetrexedPemetrexed
55150-382PemetrexedPemetrexed
42367-531Pemfexypemetrexed
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.